NTLA
Intellia Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$12.74
+0.47%Margins
Gross margin
-46.5%
EBITDA margin
-656.0%
EBIT margin
-711.7%
Net margin
-672.2%
FCF margin
-783.3%
-55.0%
Return on equity
-46.7%
Return on assets
-52.9%
Return on invested capital
0.07x
Asset turnover
-$464.0M
Cash from operations
$3.12
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026